CD11b-CD27- NK Cells Are Associated with the Progression of Lung Carcinoma

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Jin, Jing ^a   Fu, Binqing ^a,b   Mei, Xinyu ^c   Yue, Ting ^a   Sun, Rui ^a,b   Tian, Zhigang ^a,b   Wei, Haiming ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VIVO STUDY; KILLER CELL; LEWIS CARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TUMOR INFILTRATING NATURAL KILLER CELL; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD27; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; KI-67 ANTIGEN; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MICE;

MURINAE;

EID: 84875648813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061024     Document Type: Article

References (50)

1. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Smyth MJ, Hayakawa Y, Takeda K, Yagita H, (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2: 850-861.
3. Swann JB, Smyth MJ, (2007) Immune surveillance of tumors. J Clin Invest 117: 1137-1146.
4. Ljunggren HG, Malmberg KJ, (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nature Reviews Immunology 7: 329-339.
5. Chan CJ, Andrews DM, Smyth MJ, (2008) Can NK cells be a therapeutic target in human cancer? Eur J Immunol 38: 2964-2968.
6. Cerwenka A, Falk CS, Watzl C, (2007) NK cells-from basic research to cancer therapy. Eur J Immunol 37: 1161-1164.
7. Lanier LL, (2005) Nk Cell Recognition. Annual Review of Immunology 23: 225-274.
8. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, et al. (2011) Innate or Adaptive Immunity? The Example of Natural Killer Cells. Science 331: 44-49.
9. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, (2008) Functions of natural killer cells. Nature Immunology 9: 503-510.
10. Sun JC, Lanier LL, (2009) Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol 39: 2059-2064.
11. Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, et al. (2011) Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma. Cancer Research 71: 5412-5422.
12. Carrega P, Morandi B, Costa R, Frumento G, Forte G, et al. (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16- cells and display an impaired capability to kill tumor cells. Cancer 112: 863-875.
13. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, et al. (2011) Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. Journal of Clinical Investigation 121: 3609-3622.
14. Jonsson AH, Yokoyama WM, (2009) Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 101: 27-79.
15. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
16. Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, et al. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
17. Zimmer J, Béziat V, Descours B, Parizot C, Debré P, et al. (2010) NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs. PLoS ONE 5: e11966.
18. Brodin P, Kärre K, Höglund P, (2009) NK cell education: not an on-off switch but a tunable rheostat. Trends in Immunology 30: 143-149.
19. Elliott JM, Wahle JA, Yokoyama WM, (2010) MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. Journal of Experimental Medicine 207: 2073-2079.
20. Joncker NT, Shifrin N, Delebecque F, Raulet DH, (2010) Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. Journal of Experimental Medicine 207: 2065-2072.
21. Huntington ND, Vosshenrich CAJ, Di Santo JP, (2007) Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nature Reviews Immunology 7: 703-714.
22. Di Santo JP, (2008) Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur J Immunol 38: 2948-2951.
23. Freud AG, (2006) Evidence for discrete stages of human natural killer cell differentiation in vivo. Journal of Experimental Medicine 203: 1033-1043.
24. Cooper MA, Fehniger TA, Caligiuri MA, (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
25. Caligiuri MA, (2008) Human natural killer cells. Blood 112: 461-469.
26. Colucci F, Caligiuri MA, Di Santo JP, (2003) What does it take to make a natural killer? Nature Reviews Immunology 3: 413-425.
27. Fehniger TA, (2002) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
28. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, et al. (2007) CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 178: 4947-4955.
29. Hayakawa Y, Smyth MJ, (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. Journal of Immunology 176: 1517-1524.
30. Vossen MT, Matmati M, Hertoghs KM, Baars PA, Gent MR, et al. (2008) CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 180: 3739-3745.
31. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, et al. (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
32. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ, (2006) Functional subsets of mouse natural killer cells. Immunol Rev 214: 47-55.
33. Fu B, Wang F, Sun R, Ling B, Tian Z, et al. (2011) CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 133: 350-359.
34. Hayakawa Y, Sato-Matsushita M, Takeda K, Iwakura Y, Tahara H, et al. (2011) Early activation and interferon-γ production of tumor-infiltrating mature CD27high natural killer cells. Cancer Science 102: 1967-1971.
35. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, et al. (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
36. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, et al. (2009) NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. Journal of Clinical Investigation 119: 1251-1263.
37. Lee SH, Biron CA, (2010) Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections. Eur J Immunol 40: 923-932.
38. Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, et al. (1991) Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol 146: 206-210.
39. Xia Y, Borland G, Huang J, Mizukami IF, Petty HR, et al. (2002) Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J Immunol 169: 6417-6426.
40. Chen LL, He ZX, Qin L, Li QY, Shi XB, et al. (2011) Antitumor Effect of Malaria Parasite Infection in a Murine Lewis Lung Cancer Model through Induction of Innate and Adaptive Immunity. PLoS ONE 6.
41. Richards JO, Chang X, Blaser BW, Caligiuri MA, Zheng P, et al. (2006) Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood 108: 246-252.
42. Allan DS, Rybalov B, Awong G, Zuniga-Pflucker JC, Kopcow HD, et al. (2010) TGF-beta affects development and differentiation of human natural killer cell subsets. Eur J Immunol 40: 2289-2295.
43. Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CAJ, et al. (2003) GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 19: 701-711.
44. Le Maux Chansac B, Moretta A, Vergnon I, Opolon P, Lecluse Y, et al. (2005) NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol 175: 5790-5798.
45. Passlick B, Pantel K, Kubuschok B, Angstwurm M, Neher A, et al. (1996) Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells. Eur J Cancer 32A: 141-145.
46. Orange JS, Harris KE, Andzelm MM, Valter MM, Geha RS, et al. (2003) The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proceedings of the National Academy of Sciences of the United States of America 100: 14151-14156.
47. Crozat K, Eidenschenk C, Jaeger BN, Krebs P, Guia S, et al. (2011) Impact of beta2 integrin deficiency on mouse natural killer cell development and function. Blood 117: 2874-2882.
48. Groh V, Wu J, Yee C, Spies T, (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
49. Salih HR, Rammensee HG, Steinle A, (2002) Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169: 4098-4102.
50. Soderquest K, Powell N, Luci C, van Rooijen N, Hidalgo A, et al. (2011) Monocytes control natural killer cell differentiation to effector phenotypes. Blood 117: 4511-4518.